{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:10:19Z","timestamp":1773285019183,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2012R1A1A2006672"],"award-info":[{"award-number":["2012R1A1A2006672"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022544","name":"Samsung Biomedical Research Institute","doi-asserted-by":"publisher","award":["1B20812"],"award-info":[{"award-number":["1B20812"]}],"id":[{"id":"10.13039\/501100022544","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.diagmicrobio.2016.08.009","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T16:30:31Z","timestamp":1471278631000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["In vitro synergistic effects of various combinations of vancomycin and non-beta-lactams against Staphylococcus aureus with reduced susceptibility to vancomycin"],"prefix":"10.1016","volume":"86","author":[{"given":"Yu Ri","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Yang","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Eun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0005","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1128\/AAC.44.11.2991-2998.2000","article-title":"Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model","volume":"44","author":"Aeschlimann","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0010","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/163.6.1279","article-title":"Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus","volume":"163","author":"Blumberg","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/cid\/ciq067","article-title":"Antimicrobial resistance: not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy","volume":"52","author":"Chua","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0020","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement: CLSI document M100-S23","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2013"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0025","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/AAC.00437-10","article-title":"An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus","volume":"54","author":"Cui","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1396906","article-title":"Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections","volume":"36","author":"Davis","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0035","series-title":"Clinical microbiology procedures handbook","author":"Garcia","year":"2010"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0924-8579(00)00317-4","article-title":"Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents","volume":"17","author":"Gradelski","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jac\/dku352","article-title":"Randomized non-inferiority trial to compare trimethoprim\/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection","volume":"70","author":"Harbarth","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0732-8893(86)90147-1","article-title":"In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus","volume":"4","author":"Ho","year":"1986","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0055","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia: a review","volume":"312","author":"Holland","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jac\/dkl283","article-title":"Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus","volume":"58","author":"Kaka","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0065","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.amjmed.2010.05.020","article-title":"Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis","volume":"123","author":"Khawcharoenporn","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/dkt374","article-title":"Oral antibiotic treatment of staphylococcal bone and joint infections in adults","volume":"69","author":"Kim","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0075","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/jac\/dkn379","article-title":"Synergy between gemifloxacin and trimethoprim\/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus","volume":"62","author":"Leonard","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0080","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0085","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1128\/AAC.01143-09","article-title":"Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay","volume":"54","author":"Lin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0090","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0095","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/AAC.00398-11","article-title":"Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3","volume":"55","author":"Matsuo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0105","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1128\/AAC.33.12.2037","article-title":"Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species","volume":"33","author":"Rohner","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2796.2005.01598.x","article-title":"Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients","volume":"259","author":"Ruotsalainen","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0115","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1099\/jmm.0.072280-0","article-title":"Adjunctive rifampicin may improve outcomes in Staphylococcus aureus bacteraemia: a systematic review","volume":"63","author":"Russell","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0120","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/424506","article-title":"A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection","volume":"39","author":"Schrenzel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0125","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1212788","article-title":"Management of skin abscesses in the era of methicillin-resistant Staphylococcus aureus","volume":"370","author":"Singer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1473-3099(10)70285-1","article-title":"Clinical management of Staphylococcus aureus bacteraemia","volume":"11","author":"Thwaites","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0135","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/AAC.6.6.802","article-title":"Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides","volume":"6","author":"Watanakunakorm","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/jac\/20.6.839","article-title":"Bactericidal effect of ofloxacin alone and combined with fosfomycin or vancomycin against Staphylococcus aureus in vitro and in sera from volunteers","volume":"20","author":"Weber","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.009_bb0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"47","author":"Wootton","year":"2001","journal-title":"J Antimicrob Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316302462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316302462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T04:33:46Z","timestamp":1656736426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889316302462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0732889316302462"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.08.009","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro synergistic effects of various combinations of vancomycin and non-beta-lactams against Staphylococcus aureus with reduced susceptibility to vancomycin","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}